Scott M. Lippman

Also affiliated with UC San Diego Health System, University of California San Diego, University of California San Diego Medical Center, Moores Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data from Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22482656.v1

Top 100%

0DataRank

Top 100%0 citations

Shruti Bhargava, Avi Kumar, Adam M. Burgoyne, Chih‐Min Tang, Hyunho Yoon +17 more

Papers

Driven by 39 papers — median percentile 0. Top paper: “New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development”.

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development

Cancer Prevention Research(2015)10.1158/1940-6207.capr-14-0179

N/A

2.8DataRank · unranked

78 citations

Curtis R. Pickering, Vassiliki A. Papadimitrakopoulou, Jaroslav Jelinek, Steven H. Lin, William N. William +16 more

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

Genome Medicine(2021)10.1186/s13073-021-00969-w

N/A

1.9DataRank · unranked

90 citations

Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta +14 more

Future cancer research priorities in the USA: a Lancet Oncology Commission

The Lancet Oncology(2017)10.1016/s1470-2045(17)30698-8

N/A

0.801DataRank · unranked

208 citations

Chi Van Dang, David B. Agus, Brian M. Alexander, Kenneth C. Anderson, Alan Ashworth +64 more

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

Gastroenterology(2024)10.1053/j.gastro.2024.01.042

N/A

0.624DataRank · unranked

18 citations

C. Sloane Furniss, Matthew B. Yurgelun, Chinedu Ukaegbu, Pamela E. Constantinou, Ileana Fortes +23 more

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas

JCI Insight(2022)10.1172/jci.insight.161334

N/A

0.559DataRank · unranked

16 citations

Vinicius J. Campos, Daniella Vo, Caitlin Guccione, Vanae Goheen-Holland, Courtney Tindle +10 more

Integrated Germline and Somatic Features Reveal Divergent Immune Pathways Driving Response to Immune Checkpoint Blockade

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0164

N/A

0.508DataRank · unranked

11 citations

Meghana S. Pagadala, Andrea Castro, Ko-Han Lee, JungHo Kong, Kairi Tanaka +4 more

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Cancer Cell(2025)10.1016/j.ccell.2025.04.003

N/A

0.505DataRank · unranked

28 citations

Pingjun Chen, Muhammad Aminu, Jiànróng Lǐ, Junya Fujimoto, Yanhua Tian +47 more

AI-assisted Discovery of an Ethnicity-influenced Driver of Cell Transformation in Esophageal and Gastroesophageal Junction Adenocarcinomas

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.30.478408

N/A

0.114DataRank · unranked

1 citations

Vinicius J. Campos, Daniella Vo, Caitlin Guccione, Vanae Goheen-Holland, Courtney Tindle +10 more

Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-22-19

N/A

0.104DataRank · unranked

1 citations

Aaron M. Goodman, Zachary Rane, James V. Talwar, Garrett M. Frampton, Gerald P. Morris +5 more

Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01211-1

N/A

0DataRank · unranked

7 citations

Scott M. Lippman, Razelle Kurzrock, Amélie Boichard

JAK: Not Just Another Kinase

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0323

N/A

0DataRank · unranked

132 citations

Scott M. Lippman, Razelle Kurzrock, Ruchi Agashe

Somatic 9p24.1 alterations in HPV – head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2213835119

N/A

0DataRank · unranked

44 citations

Ezra E.W. Cohen, William N. William, Joy J. Bianchi, Jim Abraham, Daniel Magee +7 more

Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways

eLife(2022)10.7554/elife.75227

N/A

0DataRank · unranked

29 citations

Xin Zhao, Lizabeth Katsnelson, Elaine M Camacho-Hernandez, Angela Mermerian, Joseph C. Mays +8 more

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy

npj Precision Oncology(2022)10.1038/s41698-022-00309-0

N/A

0DataRank · unranked

17 citations

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Ryosuke Okamura, Ramez N. Eskander +7 more

Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience

The Oncologist(2020)10.1002/onco.13532

N/A

0DataRank · unranked

8 citations

Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Vincent A. Miller, Brian Leyland‐Jones +3 more

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102866

N/A

0DataRank · unranked

16 citations

Simone Lubrano, Damiano Cosimo Rigiracciolo, Daniela Nachmanson, Scott M. Lippman, Prashant Mali +3 more

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus

Nature(2023)10.1038/s41586-023-05937-5

N/A

0DataRank · unranked

191 citations

Alvin Wei Tian Ng, Patricia C. Galipeau, Xiaohong Li, Carissa A. Sanchez, Annalise Katz‐Summercorn +15 more

Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats

Nature(2023)10.1038/s41586-023-05923-x

N/A

0DataRank · unranked

79 citations

Ammal Abbasi, Dong Hyun Kim, Scott M. Lippman, Ludmil B. Alexandrov, Don W. Cleveland +1 more

KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres

Cell(2023)10.1016/j.cell.2023.03.029

N/A

0DataRank · unranked

71 citations

Aleah Goldberg, Xin Zhao, Joseph C. Mays, Pan Cheng, Adam F. Johnson +23 more

Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia

Cancer Medicine(2023)10.1002/cam4.5478

N/A

0DataRank · unranked

40 citations

Frederico O. Gleber‐Netto, Shidan Wang, Roberta Rayra Martins‐Chaves, Ricardo Santiago Gomez, Nadarajah Vigneswaran +15 more

LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics

Cancer Medicine(2023)10.1002/cam4.6000

N/A

0DataRank · unranked

32 citations

Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Pradip De, Suzanna Lee +7 more

Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort

Cancer(2023)10.1002/cncr.34607

N/A

0DataRank · unranked

14 citations

Jianjun Zhang, Xin Zhao, Edwin R. Parra, Naohiro Uraoka, Heather Lin +16 more

Pan‐cancer analysis of TIM‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity

Cancer Medicine(2023)10.1002/cam4.6844

N/A

0DataRank · unranked

13 citations

Razelle Kurzrock, Daisuke Nishizaki, Hirotaka Miyashita, Jacob J. Adashek, Suzanna Lee +7 more

Considering molecular alterations as pan-cancer tissue-agnostic targets

Nature Cancer(2023)10.1038/s43018-023-00676-y

N/A

0DataRank · unranked

11 citations

Shumei Kato, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock, Jacob J. Adashek

Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer

medRxiv(2023)10.1101/2023.02.23.23285869

N/A

0DataRank · unranked

8 citations

Ammal Abbasi, Marcos Díaz‐Gay, Loïck Galland, Scott M. Lippman, Sylvain Ladoire +2 more

Data from 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

(2023)10.1158/0008-5472.c.6511397.v1

N/A

0DataRank · unranked

0 citations

Xiaodong Feng, Alfredo Molinolo, Daniel Martı́n, Lynn Vitale‐Cross, Nijiro Nohata +15 more

Supplementary Data from Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22482656.v1

Top 100%

0DataRank

Top 100%0 citations

Shruti Bhargava, Avi Kumar, Adam M. Burgoyne, Chih‐Min Tang, Hyunho Yoon +17 more

Data from Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

(2023)10.1158/1078-0432.c.6530975.v1

N/A

0DataRank · unranked

0 citations

Shruti Bhargava, Avi Kumar, Adam M. Burgoyne, Chih‐Min Tang, Hyunho Yoon +17 more

Pan-cancer analysis of IDO1 transcriptome expression and its impact on outcome in patients treated with immune checkpoint inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2614

N/A

0DataRank · unranked

0 citations

Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary Nesline +6 more

If it’s a target, it’s a pan-cancer target: Tissue is not the issue

Cancer Treatment Reviews(2024)10.1016/j.ctrv.2024.102721

N/A

0DataRank · unranked

29 citations

Shumei Kato, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock, Jacob J. Adashek

Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes

Supportive Care in Cancer(2020)10.1007/s00520-020-05294-3

N/A

0DataRank · unranked

15 citations

Andrew L. Ries, Scott M. Lippman, Mark M. Fuster, Duc Ha

Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.12.020

N/A

0DataRank · unranked

13 citations

Bin Liu, William N. William, Kaloyan M. Tsanov, Yu-Jui Ho, Francisco M. Barriga +9 more

Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy

iScience(2024)10.1016/j.isci.2024.110465

N/A

0DataRank · unranked

10 citations

Shumei Kato, Jordan S. Lim, Ki Hwan Kim, Hyo Jeong Lim, Ryosuke Okamura +6 more

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy

iScience(2024)10.1016/j.isci.2024.109632

N/A

0DataRank · unranked

10 citations

Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary Nesline +6 more

Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism

Cancer Prevention Research(2024)10.1158/1940-6207.capr-24-0124

N/A

0DataRank · unranked

3 citations

Sendi Rafael Adame-Garcia, Keiichi Koshizuka, Pham Thuy Tien Vo, Thomas S. Hoang, Kuniaki Sato +7 more

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

UNC Libraries(2020)10.17615/seks-5275

N/A

0DataRank · unranked

0 citations

Scott M. Lippman, Ezra E.W. Cohen, Trey Ideker, Ann Marie Egloff, John Paul Shen +8 more

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Nature Communications(2020)10.1038/s41467-020-18613-3

N/A

0DataRank · unranked

303 citations

Ki Hwan Kim, Hyo Jeong Lim, Amélie Boichard, Mina Nikanjam, Elizabeth Weihe +17 more

Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2092

N/A

0DataRank · unranked

37 citations

Shruti Bhargava, Avi Kumar, Adam M. Burgoyne, Chih-Min Tang, Hyunho Yoon +17 more

Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study

Cancer Prevention Research(2021)10.1158/1940-6207.capr-20-0642

N/A

0DataRank · unranked

23 citations

Matthew B. Yurgelun, Chinedu Ukaegbu, Pamela E. Constantinou, Catherine C. Lafferty, Eliana R. Talcove-Berko +23 more

Scott M. Lippman

Indexed papers

Top data-sharing exemplar

Papers